Strain Summary(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1
Strain Name |
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 |
Strain Type(s) |
other |
Strain Synonym(s) |
(BALB/cByJ _ C57BL/6J)F1 _ (C3H/HeJ _ DBA/2J)F1 • (BALB/cByJ X C57BL/6J)F1 mothers (JAX #100,009) and (C3H/HeJ X DBA/2J)F1 fathers (JAX #100,004) • (BALB/cByJ x C57BL/6J)F1 mothers (JAX stock 100009) and (C3H/HeJ x DBA/2J)F1 fathers (JAX stock 100004) • (BALB/cByJ x C57BL/6J)F1 X (C3H/HeJ x DBA/2J)F1 • F2 of (BALB/cByJ x C57BL/6J)F1 X (C3H/HeJ x DBA/2J)F1 • Het3 • HET3 • UM HET3 • UM-HET3 |
Description |
(BALB/cByJ x C57BL/6J)F1 mothers (JAX stock 100009) x (C3H/HeJ x DBA/2J)F1 fathers (JAX stock 100004) |
Frequency | ||||||||
---|---|---|---|---|---|---|---|---|
Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
Adipose tissue liposarcoma | Adipose tissue |
0 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Adipose tissue liposarcoma | Adipose tissue | rapamycin |
2.27 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Adrenal gland - Cortex hyperplasia | Adrenal gland - Cortex |
0 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Adrenal gland - Cortex hyperplasia | Adrenal gland - Cortex | canagliflozin (Cana) |
0 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Adrenal gland - Cortex neoplasm | Adrenal gland - Cortex |
0 |
26 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Adrenal gland - Cortex neoplasm | Adrenal gland - Cortex | canagliflozin (Cana) |
7.7 |
6.7 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Adrenal gland - Subcapsular cell hyperplasia - spindle cell | Adrenal gland - Subcapsular cell |
0 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Adrenal gland - Subcapsular cell hyperplasia - spindle cell | Adrenal gland - Subcapsular cell | canagliflozin (Cana) |
0 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Adrenal gland carcinoma | Adrenal gland |
0 - 4.35 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Adrenal gland hyperplasia | Adrenal gland |
observed |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Adrenal gland hyperplasia | Adrenal gland | rapamycin |
observed |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Blood neoplasia | Blood |
31 |
14 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Blood neoplasia | Blood | canagliflozin (Cana) |
31 |
13 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Blood vessel hemangiosarcoma | Blood vessel |
7.3 |
7.8 |
21.74 |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 ⋅ Snyder JM, Geroscience 2023;45(1):385-397 |
||
Blood vessel hemangiosarcoma | Blood vessel | rapamycin |
13.64 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Blood vessel hemangiosarcoma | Blood vessel | canagliflozin (Cana) |
5.1 |
14 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
6.52 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast | rapamycin |
2.27 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Leukocyte lymphoma | Leukocyte |
32.61 |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Leukocyte lymphoma | Leukocyte | rapamycin |
18.18 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Liver - Hepatocyte hyperplasia | Liver - Hepatocyte |
9.1 |
24 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Liver - Hepatocyte hyperplasia | Liver - Hepatocyte | canagliflozin (Cana) |
6.8 |
17 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Liver carcinoma | Liver |
4.35 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Liver carcinoma | Liver | rapamycin |
9.09 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Liver foci | Liver |
3.6 |
14 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Liver foci | Liver | canagliflozin (Cana) |
5.1 |
7.9 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Liver hepatocellular adenoma | Liver |
7.3 |
9.8 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Liver hepatocellular adenoma | Liver | canagliflozin (Cana) |
8.5 |
16 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Liver hepatocellular carcinoma | Liver |
1.8 |
7.8 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Liver hepatocellular carcinoma | Liver | canagliflozin (Cana) |
1.7 |
4.8 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Lung adenocarcinoma | Lung |
observed |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Lung adenocarcinoma | Lung | rapamycin |
observed |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Lung adenoma | Lung |
11 |
31 |
observed |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 ⋅ Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Lung adenoma | Lung | canagliflozin (Cana) |
14 |
27 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Lung carcinoma | Lung |
1.8 |
12 |
15.22 |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 ⋅ Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 ⋅ Snyder JM, Geroscience 2023;45(1):385-397 |
||
Lung carcinoma | Lung | rapamycin |
34.09 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Lung carcinoma | Lung | canagliflozin (Cana) |
5.1 |
7.9 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Lung hyperplasia | Lung |
16 |
24 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Lung hyperplasia | Lung | canagliflozin (Cana) |
22 |
30 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Mammary gland carcinoma | Mammary gland |
4.55 - 8.7 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Ovary cyst | Ovary |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||||
Ovary cyst | Ovary | canagliflozin (Cana) |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Ovary hyperplasia | Ovary |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||||
Ovary hyperplasia | Ovary | canagliflozin (Cana) |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Pancreas - Islet of Langerhans hyperplasia | Pancreas - Islet of Langerhans |
27 |
78 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Pancreas - Islet of Langerhans hyperplasia | Pancreas - Islet of Langerhans | canagliflozin (Cana) |
28 |
69 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Skin - Melanocyte melanoma | Skin - Melanocyte |
0 - 2.27 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Skin carcinoma | Skin |
0 - 2.27 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Thymus thymoma | Thymus |
0 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Thymus thymoma | Thymus | rapamycin |
2.27 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
6.5 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell | canagliflozin (Cana) |
0 |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Thyroid gland - Follicular cell hyperplasia | Thyroid gland - Follicular cell |
11 |
4.3 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
||||
Thyroid gland - Follicular cell hyperplasia | Thyroid gland - Follicular cell | canagliflozin (Cana) |
24 |
14 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||
Thyroid gland carcinoma | Thyroid gland |
2.17 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Thyroid gland carcinoma | Thyroid gland | rapamycin |
0 |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
||||
Uterus - Endometrium carcinoma | Uterus - Endometrium |
observed |
References: Miller RA, J Gerontol A Biol Sci Med Sci 2011 Feb;66(2):191-201 |
|||||
Uterus - Endometrium hyperplasia | Uterus - Endometrium |
observed |
References: Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
|||||
Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |
|||||
Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium | canagliflozin (Cana) |
0 |
References: Snyder JM, Geroscience 2023;45(1):385-397 |